• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alivus Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75599.0
  • ISIN : INE03Q201024
1,366.30 -53 (-3.70%)
  • As on 06 Sep 2026 (EOD)

  • Today’s Low

    1,356.40

  • Today’s High

    1,446.90

  • Open

    1,418.90

  • Perv Close

    1,418.80

  • 52W Low

    819.00

  • 52W High

    1,493.80

Key Indicators

  • P/E(TTM)

    26.99

  • Mar.Cap (₹Cr.)

    16,774.26

  • Div & Yield %

    0.37

  • Book Value(₹)

    271.41

  • Debt-Equity Ratio

    -3.70

  • AGM Date

    04-Sep-2026

  • EPS

    50.64

  • P/E Ratio

    26.99

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    16,774.26

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.55

  • BV (₹)

    271.40

  • Sales( ₹ in Cr.)

    2,551.83

  • NP (in Cr.)

    549.68

  • NP Var(%)

    15.0

  • Div%

    250.0

  • CPS (₹)

    50.90

  • EPS (₹)

    44.80

  • Traded Value (₹ in Lakhs)

    16,781.63

  • 52 Week High

    1,493.80

  • 52 Week Low

    819.00

  • Price BSE

    1367.0

  • Price NSE

    1,366.00

  • Market Capital( in Cr.)

    16,781.63

  • P/C Ratio

    26.90

  • P/E Ratio

    30.50

  • Price Vs.BV

    44.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,551.83 2,386.88 2,283.21 2,161.22 2,123.21 1,885.17
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,551.83 2,386.88 2,283.21 2,161.22 2,123.21 1,885.17
Other Income 60.41 34.57 12.04 28.96 14.70 0.81
Stock Adjustments -3.56 -27.35 56.57 84.44 -41.32 70.70
Total Income 2,608.68 2,394.10 2,351.82 2,274.62 2,096.59 1,956.68
EXPENDITURE :            
Raw Materials 1,024.27 1,010.09 1,025.21 1,068.56 977.96 948.17
Power and Fuel Cost 113.88 117.24 112.46 115.60 100.92 74.19
Employee Cost 272.47 251.70 258.16 180.18 168.72 149.13
Other Manufacturing Expenses 212.31 177.41 163.64 137.17 124.04 107.32
Selling and Administration Expenses 88.46 83.58 64.12 65.47 48.19 48.50
Miscellaneous Expenses 65.26 36.93 41.97 36.39 46.01 37.49
Employee Benefit Expenses 272.47 251.70 258.16 180.18 168.72 149.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,776.64 1,676.95 1,665.54 1,603.36 1,465.83 1,364.80
Operating Profit 832.04 717.15 686.29 671.25 630.76 591.89
Interest 5.37 2.41 1.55 0.55 27.96 87.55
Gross Profit 826.67 714.74 684.74 670.70 602.80 504.34
Depreciation 75.36 60.61 53.45 42.09 37.88 33.39
Profit Before Tax 751.31 654.13 631.29 628.61 564.92 470.95
Current Tax 183.89 162.44 152.21 150.61 137.63 112.75
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.93 6.06 8.19 11.04 8.57 6.62
Reported Net Profit 564.48 485.63 470.89 466.96 418.72 351.58
Extraordinary Items 14.81 7.29 -0.53 -0.41 -0.55 -0.44
Adjusted Net Profit 549.67 478.34 471.42 467.37 419.27 352.02
Adjustment below Net Profit 1.22 -0.25 -5.46 -0.29 -19.50 -0.53
P & L Balance brought forward 1,777.18 1,291.80 1,102.06 1,021.35 750.79 399.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 61.34 0.00 275.69 385.96 128.65 0.00
P & L Balance carried down 2,281.55 1,777.18 1,291.80 1,102.06 1,021.35 750.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 250.00 1,125.00 2,100.00 1,050.00 0.00
Dividend Per Share(Rs) 5.00 5.00 22.50 42.00 21.00 0.00
Earnings Per Share-Unit Curr 45.99 39.63 38.43 38.11 34.17 358.76
Earnings Per Share(Adj)-Unit Curr 45.99 39.63 38.43 38.11 34.17 -
Book Value 271.49 229.92 190.35 174.51 167.66 768.11
Book Value(Adj)-Unit Curr 271.49 229.92 190.35 174.51 167.66 -

Shareholding Pattern

  • Promoter Group

    74.87%

  • Public Share Holding

    25.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,896,285 74.87 91,896,285 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 91,896,285 74.87 91,896,285 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,799,677 5.54 6,799,677 68
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 333,862 0.27 333,862 1
Mutual Funds / UTI 6,939,496 5.65 6,939,496 14
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,541,560 1.26 1,541,560 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,614,595 12.72 15,614,595 97
2] Non Institution
Bodies Corporate 1,552,820 1.27 1,552,820 854
Clearing Members 685 0.00 685 3
Directors of their Relatives 157,600 0.13 157,600 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 841,882 0.69 841,882 2,966
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 303,592 0.25 303,592 2,484
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 918,073 0.75 918,073 5
Individuals holding nominal share capital up to Rs. 1 lakh 11,415,877 9.30 11,415,877 119,139
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 38,039 0.03 38,039 7
Others 0 0.00 0 0
Sub Total 15,228,568 12.41 15,228,568 125,461
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 122,739,448 100.00 122,739,448 125,559

Company Background

Alivus Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alivus Life Sciences Ltd
  • BSE Code : 75599.0
  • ISIN : INE03Q201024

  • Incorporation Year

    2011

  • Registered Office

    Plot No. 170-172 Chandramouli
    Industrial Est.Mohol Bazarpeth, Solapur,
    Maharashtra-413213

  • Telephone

    91-2189-234456/234246

  • FAX

  • Chairman

    HIREN KARSANBHAI PATEL

  • Managing Director

    Yasir Yusufali Rawjee

  • Company Secretary

    Rudalf Corriea

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Alivus Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alivus Life 1,366.90 2,612.24 2,551.83 27.83 23.95
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 393.10 354.33 41.34 15.94
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77